 PLANO, Texas, March 29, 2021 GLOBE NEWSWIRE -- Reata Pharmaceuticals, Inc. Nasdaq: RETA Reata, the Company, or we, a clinical-stage biopharmaceutical company, today announced that abstracts highlighting clinical data for bardoxolone methyl bardoxolone will be presented at two upcoming nephrology conferences including The World Congress of Nephrology 2021 being held virtually from April 15 19, 2021 and the 58th European Renal Association and European Dialysis and Transplant Association ERA-EDTA Congress being held from June 5 8, 2021 in Berlin, Germany and virtually. 